127 related articles for article (PubMed ID: 8587046)
1. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.
Matsubara K; Abe K; Irie T; Uekama K
J Pharm Sci; 1995 Nov; 84(11):1295-300. PubMed ID: 8587046
[TBL] [Abstract][Full Text] [Related]
2. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin.
Uekama K; Arima H; Irie T; Matsubara K; Kuriki T
J Pharm Pharmacol; 1989 Dec; 41(12):874-6. PubMed ID: 2576455
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-beta-cyclodextrin.
Matsubara K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):378-83. PubMed ID: 9118452
[TBL] [Abstract][Full Text] [Related]
5. Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate.
Matsubara K; Ando Y; Irie T; Uekama K
Pharm Res; 1997 Oct; 14(10):1401-5. PubMed ID: 9358553
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of buserelin and gonadorelin in suspensions.
Dolińska B; Ryszka F; Szulc B
Boll Chim Farm; 1995 Sep; 134(8):459-60. PubMed ID: 7576445
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
8. The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats.
Raehs SC; Sandow J; Wirth K; Merkle HP
Pharm Res; 1988 Nov; 5(11):689-93. PubMed ID: 3150047
[TBL] [Abstract][Full Text] [Related]
9. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
Schipper NG; Verhoef JC; De Lannoy LM; Romeijn SG; Brakkee JH; Wiegant VM; Gispen WH; Merkus FW
Br J Pharmacol; 1993 Dec; 110(4):1335-40. PubMed ID: 8306072
[TBL] [Abstract][Full Text] [Related]
10. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
[TBL] [Abstract][Full Text] [Related]
11. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Hermens WA; Deurloo MJ; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318
[TBL] [Abstract][Full Text] [Related]
12. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
13. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Bioavailability of the GnRH Analogs in the Form of Solution and Zn
Suszka-Świtek A; Ryszka F; Dolińska B; Dec R; Danch A; Filipczyk Ł; Wiaderkiewicz R
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):251-259. PubMed ID: 27180066
[TBL] [Abstract][Full Text] [Related]
17. The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies.
Marttin E; Verhoef JC; Spies F; van der Meulen J; Nagelkerke JF; Koerten HK; Merkus FW
J Control Release; 1999 Feb; 57(2):205-13. PubMed ID: 9971905
[TBL] [Abstract][Full Text] [Related]
18. Disposition of 3H-labelled buserelin continuously infused into rats.
Heinrich N; Albrecht E; Sandow J; Kertscher U; Lorenz D; Oehlke J; Berger H
Eur J Drug Metab Pharmacokinet; 1996; 21(4):345-50. PubMed ID: 9074900
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.
Shao Z; Li Y; Chermak T; Mitra AK
Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
